Evidence map›Paper›PMID 41933288›Full record

ArticleBMC infectious diseases2026

Descriptive epidemiology of opportunistic infections among patients with advanced HIV disease in Kinshasa, Democratic Republic of Congo.

Lucie Matsuela Bakana, Denis Mpika Mpika, Doudou Malekita Yobi, Pius Zakayi Kabututu, Patrick Tembeni Mwasomi, Pulcherie Ditondo, Marcel Mbula Mambimbi, Aimé Nkoso Mboyo, Tony Kalwangila Sequeira, Katrien Lagrou and 2 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lucie Matsuela BakanaDepartment of Oral and Maxillofacial Surgery, University Clinics of Kinshasa, Faculty of Dental Medicine, Kinshasa, Democratic Republic of Congo.
Denis Mpika MpikaService of Molecular Biology, Department of Basic Sciences, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Doudou Malekita YobiService of Molecular Biology, Department of Basic Sciences, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of Congo.ORCID http://orcid.org/0000-0002-8703-1269
Pius Zakayi KabututuService of Molecular Biology, Department of Basic Sciences, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of Congo.ORCID http://orcid.org/0000-0002-1773-8533
Patrick Tembeni MwasomiMédecins Sans Frontières (-Belgium), Kinshasa, Democratic Republic of Congo.
Pulcherie DitondoMédecins Sans Frontières (-Belgium), Kinshasa, Democratic Republic of Congo.
Marcel Mbula MambimbiInfectious Diseases Service, Department of Internal Medicine/Department of Tropical Medicine, University Clinics of Kinshasa, Kinshasa, Democratic Republic of Congo.
Aimé Nkoso MboyoProgramme National de Lutte contre le SIDA/IST, Kinshasa, Democratic Republic of Congo.
Tony Kalwangila SequeiraProgramme National de Lutte contre le SIDA/IST, Kinshasa, Democratic Republic of Congo.
Katrien LagrouDepartment of Laboratory Medicine, National Reference Center for Mycosis, University Hospitals Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0001-8668-1350
Georges Lelo MvumbiService of Molecular Biology, Department of Basic Sciences, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of Congo.ORCID http://orcid.org/0000-0001-7081-2192
Bive Bive ZonoService of Molecular Biology, Department of Basic Sciences, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of Congo. bive.zono@unikin.ac.cd.ORCID http://orcid.org/0000-0002-0084-5068

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough people living with HIV (PLHIV) increasingly have access to antiretroviral therapy (ART) worldwide, the recurrence of advanced HIV disease (AHD) remains a major concern, exposing them to an enhanced risk of opportunistic infections (OIs) and subsequent death. We aimed here to describe the epidemiology of OIs among patients with AHD in Kinshasa (Democratic Republic of Congo, DRC) to inform future actions against AHD-related deaths.

methodsA retrospective cohort study was conducted among consecutive AHD patients admitted to Biyela Hospital Center in Kinshasa (DRC)—a peripheral clinic supported by Médecins Sans Frontières (MSF)-Belgium, between June 2021 and December 2023. The diagnosis of OIs was mainly based on MSF’s advanced HIV management guidelines, establishing the diagnosis of tuberculosis using Determine TB-LAM Ag test and/or Xpert MTB/RIF, cryptococcal meningitis using the CrAg LFA antigen test, and malaria and syphilis using the corresponding Rapid diagnostic tests. For other OIs such as cerebral toxoplasmosis, oropharyngeal candidiasis, Pneumocystis jirovecii pneumonia, and nonspecific bacterial infections, diagnosis was essentially based on the clinician’s clinical presumption, due to resource limitations. Descriptive statistics were performed using SPSS version 27.00.

resultsAmong the 130 included AHD patients (58.8% female, mean age 42 ± 16 years), 59.2% presented with multiple OIs. The most prevalent OIs were meningeal tuberculosis (61.5%), cerebral toxoplasmosis (51.5%), nonspecific bacterial pneumonia (33.1%), pulmonary tuberculosis (32.2%), cryptococcal meningitis (20.0%), nonspecific bacterial meningitis (18.5%), oropharyngeal candidiasis (17.7%), and cerebral malaria (10.8%). The clinical presentation of meningeal tuberculosis, cerebral toxoplasmosis, nonspecific bacterial pneumonia, nonspecific bacterial meningitis, and pulmonary tuberculosis was mainly characterized by fever (75%, 72.7%, 79.1%, 75%, 67.5%, respectively); cryptococcal meningitis by incoherent speech (77.7%); and oropharyngeal candidiasis by weight loss (68.2%).

conclusionsPatients with AHD in Kinshasa (DRC) frequently experience multiple OIs. While the majority of these OIs are commonly recognized in the end-stage of HIV infection (tuberculosis, cerebral toxoplasmosis, cryptococcal meningitis, nonspecific bacterial infections, oropharyngeal candidiasis), cerebral malaria is another condition that should be considered in the DRC context.

Indexed as

AIDS-Related Opportunistic InfectionsHIV InfectionsAdultDemocratic Republic of the CongoFemaleHumansMaleMiddle AgedRetrospective StudiesYoung AdultAdvanced HIV diseaseCryptococcosisDRCToxoplasmosisTuberculosis

Identifiers

PMID41933288
PMCPMC13173905

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.